SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
T/FIF Portfolio
An SI Board Since August 1998
Posts SubjectMarks Bans
1073 31 0
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
373 So literal. I was mucking with non-secretor lines early, just as you were. Goscaram(o)uche-1/7/1999
372 But didn't monoclonal publications start coming out of Cambridge in 1975? Henry Niman-1/7/1999
371 No, Henry, '82 was when the first USC publications appeared....... Prog Clscaram(o)uche-1/7/1999
370 Rick, Monoclonals began coming out of Cambridge in 1975. I didn't think thHenry Niman-1/7/1999
369 <i>Bayer sure does seem to be committed to asthma</i> If you have Mike McFarland-1/7/1999
368 For those who aren't familiar with the work, a recent abstract is appended.scaram(o)uche-1/7/1999
367 Hi Rick. Here's some more data to add to your antiangiogenesis folder. MaybEZLibra-1/6/1999
366 Steve: Don't know GLGC well enough to compare them to anyone. It's onscaram(o)uche-1/6/1999
365 Joe: Yeah, I remember the CEGE hype. At that time, I figured that AVGN was inscaram(o)uche-1/6/1999
364 Richard--The PRs from CEGE and AVGN both cite the work of Mark Kay of Stanford JOEBT1-1/5/1999
363 Richard; How do you compare CRGN and GLGC? AXPH announced another advancementSteve Lokness-1/5/1999
362 JM: Don't know. Mike has raised the same question about one of the two vescaram(o)uche-1/5/1999
361 I just checked. The Avigen presentation to which I referred was on August 5th.JMarcus-1/5/1999
360 Here's the ARIA release (not sourced from ARIA, but they have one out that scaram(o)uche-1/5/1999
359 Any idea whether or not CEGE and AVGN have an actual or possible patent conflicJMarcus-1/5/1999
358 Larry: I saw the Janus Report too, and felt the same as you did when I read itMicawber-1/5/1999
357 bid is 8 1/16, gonna back out of 1.3K of that impulse 2.3K REGN buy (eom) scaram(o)uche-1/5/1999
356 ask 7, 1000 CRGN purchased for each portfolio (eom) scaram(o)uche-1/5/1999
355 Joe: I bought some, not enough, when the recent news regarding AMGN/epo/TKTX ascaram(o)uche-1/5/1999
354 Richard--The following PR from CEGE looks incredibly promising to me. JOEBT1-1/4/1999
353 cutting INCY back to "hold forever" position, to 200 shares from 500,scaram(o)uche-1/4/1999
352 played SCIO in "bounce" already, and currently have enough there? Hoscaram(o)uche-1/4/1999
351 No consensus now or possibly ever. <G> AVIR has had a couple of mentionsBiomaven-1/4/1999
350 Cash burning hole in pocket. Any consensus from your new thread? scaram(o)uche-1/4/1999
349 Mike: Don't know. I love the company, but.... management just hasn'scaram(o)uche-1/4/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News